Birmingham biotech company creates new division
A local biotech company has created a new unit of its contract research organization services business.
DiscoveryBioMed launched Sentirix, a unit based on the company’s continuing five-year collaboration with the Philadelphia-based Monell Chemical Senses Center. The unit will be located in Birmingham. According to the company, future labs for studies and chemistry are envisioned but details are no t available yet.
According to DiscoveryBioMed CEO Dr. Erik Schwiebert, the name Sentirix is derived…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Tyler Patchen Source Type: news